Biofirst S.A., headquartered in Belgium, is a prominent player in the biotechnology industry, specialising in innovative solutions for healthcare and agriculture. Founded in the early 2000s, the company has achieved significant milestones, establishing itself as a leader in the development of biopharmaceuticals and bio-based products. With a focus on sustainable practices, Biofirst S.A. offers a range of unique products, including advanced biopesticides and biofertilisers, designed to enhance crop yield while minimising environmental impact. The company’s commitment to research and development has positioned it at the forefront of the market, earning recognition for its contributions to sustainable agriculture. Operating primarily in Europe, Biofirst S.A. continues to expand its influence, driven by a dedication to innovation and quality. Its notable achievements underscore its role as a trusted partner in the biotechnology sector, committed to advancing both health and environmental sustainability.
How does Biofirst S.A.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Biofirst S.A.'s score of 11 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, Biofirst S.A. reported total carbon emissions of approximately 27,719,300 kg CO2e, with Scope 1 and 2 emissions accounting for about 24,394,000 kg CO2e and Scope 3 emissions reaching approximately 277,193,000 kg CO2e. Notably, the waste generated in operations contributed about 28,604,000 kg CO2e to the Scope 3 total. Comparatively, in 2019, the company’s emissions were significantly lower, with Scope 1 and 2 emissions at about 19,867,000 kg CO2e and Scope 3 emissions at approximately 1,375,000 kg CO2e. This indicates a substantial increase in emissions over the five-year period, particularly in Scope 3 emissions. Biofirst S.A. does not currently have specific reduction targets or initiatives documented, nor does it participate in the Science Based Targets initiative (SBTi). The emissions data is cascaded from its parent company, Floridienne S.A., reflecting the broader corporate family’s environmental impact. Overall, while Biofirst S.A. has made strides in reporting its emissions, the lack of reduction commitments highlights an area for potential improvement in its climate strategy.
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2024 | |
|---|---|---|
| Scope 1 | - | - |
| Scope 2 | - | - |
| Scope 3 | 1,375,000 | 000,000,000 |
Biofirst S.A.'s Scope 3 emissions, which increased significantly last year and increased significantly since 2019, demonstrating supply chain emissions tracking. Their carbon footprint includes supplier sustainability and value chain emissions data across Scope 3 categories, with "Waste Generated in Operations" being the primary emissions source at 10% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Biofirst S.A. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.